文献速递前列腺癌

老年晚期前列腺癌患者的风险评估与合理管理:系统综述

Risk Assessment and Considerations for Proper Management of Elderly Men with Advanced Prostate Cancer: A Systematic Review.
PubMed 文献 · Eur Urol Oncol · 2020-05-26

结论支持对癌症风险、衰老及治疗副作用进行多维度评估,但缺乏前列腺癌专用的老年风险分层系统,推荐多基于改编的老年肿瘤学方法和专家共识。

要点

  • 老年前列腺癌治疗决策需综合评估癌症风险、衰老程度及治疗副作用。
  • 系统治疗获益在老年患者中可延续,但需个体化评估。
  • 目前缺乏前列腺癌专用的老年风险分层系统,推荐多基于专家共识。

核心结论

  • 老年前列腺癌患者的照护应整合癌症风险评估、衰老评估及对治疗影响的理解,以提供全面且个性化的治疗决策指导。

主要发现

  • 常用于前列腺癌的系统治疗获益可延伸至老年患者。
  • 证据支持对癌症和衰老风险进行多维度评估,并理解治疗副作用以优化治疗决策。

关键数值与推荐

  • 缺乏前列腺癌专用的老年风险分层系统,推荐主要基于改编的老年肿瘤学方法和专家共识。

临床怎么用

  • 临床应结合癌症风险、衰老评估和治疗副作用,为老年患者提供个性化和全面的治疗决策指导。

局限性

  • 缺乏前列腺癌专用的老年风险分层系统,证据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Treatment decisions for elderly men with prostate cancer are complicated by the intersection of competing risks of cancer, potential complications of treatment, and individual patients' comorbidities. OBJECTIVE: To perform a systematic review of data guiding the assessment of elderly prostate cancer patients that addresses the risk from cancer and treatment, and to discuss a patient-centered approach to incorporating these factors into decision making. EVIDENCE ACQUISITION: Evidence was gathered via a systematic review of the current literature. The search strategy used the terms prostate cancer, elderly, geriatric, >75 yr of age, risk assessment, and treatment in several combinations, and was limited to phase ≥ II clinical trials published between January 2008 and November 2018. Additional supporting literature for the discussion was pulled by hand search. EVIDENCE SYNTHESIS: The benefits of treatment identified for systemic therapies commonly used to treat men with prostate in general extend to elderly patients. Evidence supports a multifaceted assessment of the risks of cancer and aging, and an understanding of the side effects of treatment to optimally guide therapeutic decision making for elderly patients. There is little evidence defining a geriatric risk stratification system specific to prostate cancer, and recommendations are predominantly based on adapted geriatric oncology approaches and expert consensus. CONCLUSIONS: The care of elderly men with prostate cancer should incorporate a review of cancer risk, an assessment of aging, and an understanding of the effects of treatment to provide the patient with thorough and personalized guidance for treatment decisions. Future studies of elderly men with prostate cancer can define and validate ideal risk stratification methods as well as management approaches that may be distinct from those for younger populations. PATIENT SUMMARY: Treatment decisions for elderly men with prostate cancer require consideration of the risk posed by the cancer coupled with an understanding of the patient's general health status.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Shevach JW, Weiner AB, Kasimer RN, et al. Risk Assessment and Considerations for Proper Management of Elderly Men with Advanced Prostate Cancer: A Systematic Review. Eur Urol Oncol. 2020. PMID: 32471792. doi:10.1016/j.euo.2020.03.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。